Lappe Mark 13D/13G Filings for Inhibrx Biosciences, Inc. (INBX)

Lappe Mark 13D and 13G filings for Inhibrx Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-26
4:16 pm
Purchase		 2024-09-12 13D Inhibrx Biosciences, Inc.
INBX		 Lappe Mark 925,413
6.400%		 164,000increase
(+21.54%)		 Filing
2024-06-03
8:43 pm
Purchase		 2024-05-29 13D Inhibrx Biosciences, Inc.
INBX		 Lappe Mark 761,413
5.260%		 761,413increase
(New Position)		 Filing